According to IMARC Group’s latest report, titled “Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, The study provides a detailed analysis of the industry, including the global precision medicine market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the Precision Medicine Market?

The global precision medicine market size reached US$ 68.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 123.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.7% during 2023-2028.

What is Precision Medicine?

Precision medicine harnesses the unique interplay of a person's environment, genetic makeup, and lifestyle to prevent and diagnose diseases. This personalized approach helps predict an individual's susceptibility to various diseases, improves disease detection, and facilitates more effective drug prescriptions. It is a cost-effective and time-saving method that reduces the failure rate of pharmaceutical clinical trials, benefiting patients and pharmaceutical companies alike. It is widely utilized in predicting the risk of genetic disorders being passed on to offspring and diagnosing chromosomal abnormalities in the fetus, which is especially crucial in prenatal care. The approach relies on various tools, including advanced imaging, genetic testing, and sophisticated data analytics. By analyzing large amounts of data, physicians can study the root cause of disease and develop more targeted treatments that address the specific needs of each patient.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/precision-medicine-market/requestsample

What are the Growth Prospects and Trends in the Precision Medicine Industry?

The COVID-19 pandemic has burgeoned the need for precision medicine, which represents one of the primary factors boosting precision medicine market growth. Additionally, the increasing prevalence of cancer has surged the demand for precision medicine in the diagnosis, treatment, and monitoring of cancer patients, which, in turn, is propelling the market growth. Furthermore, the expanding pipeline of drug candidates in clinical trials, particularly in the field of oncology, has provided a strong impetus to market growth. Apart from this, the industry has witnessed substantial investments in research and development (R&D) initiatives aimed at developing cost-effective and advanced techniques, such as targeted sequencing, enabling precise treatment strategies, which is favoring the market growth.   

Who are the Key Players Operating in the Precision Medicine Market?

The competitive landscape of the industry has also been examined along with the profiles of the key players:

  • AstraZeneca plc
  • Bayer AG
  • BioMérieux SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA, Novartis AG
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

What is Included in Market Segmentation?

The report has categorized the market based on product, technology, application, end user and region.

Breakup by Product:

  • Consumables
  • Instruments
  • Services

Anaysed by Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Based on Application:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others

Market by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others

Regional Analysis:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Key Highlights of The Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Website: https://www.imarcgroup.com/

Follow us on twitter: @ImarcServices

LinkedIn: https://www.linkedin.com/company/imarc-group